Clinical trial
Observational Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
NCT06964685 is registered in ClinicalTrials.gov with Abiomed Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
- Lead sponsor
- Abiomed Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 10, 2025
- Completion date
- October 30, 2028
- Enrollment
- 350 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
ami cardiogenic shock